NTRK1 and neoplasm: TKIs interfere with these pathways in a nonspecific manner, affecting multiple receptor tyrosine kinases involved in OS growth, such as those regulating tumor angiogenesis (vascular endothelial growth factor receptor •1, •2, and •3) and cellular recruitment to the TME (platelet derived growth factor and fibroblast growth factor receptor) [63].